Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Vanda Pharmaceuticals
(NQ:
VNDA
)
7.650
-0.180 (-2.30%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 3, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
594,054
Open
7.750
Bid (Size)
7.300 (1)
Ask (Size)
8.030 (1)
Prev. Close
7.830
Today's Range
7.580 - 7.870
52wk Range
6.730 - 14.15
Shares Outstanding
55,638,166
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
Vanda Pharma's Antipsychotic Shows Improved Severity In Bipolar Disorder
December 19, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
December 16, 2022
During Friday's trading, 293 companies set new 52-week lows.
Via
Benzinga
Performance
YTD
+3.10%
+3.10%
1 Month
+4.79%
+4.79%
3 Month
-27.97%
-27.97%
6 Month
-27.28%
-27.28%
1 Year
-36.41%
-36.41%
More News
Read More
JetBlue Airways, Pacira BioSciences And Some Other Big Stocks Moving Lower On Tuesday
December 13, 2022
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
December 13, 2022
Via
Benzinga
Looking Into Vanda Pharmaceuticals's Return On Capital Employed
August 10, 2022
Via
Benzinga
Recap: Vanda Pharma Q2 Earnings
August 03, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
December 14, 2022
Via
Benzinga
Why OpGen Shares Are Trading Higher By 220%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session
December 13, 2022
Via
Benzinga
Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial
August 03, 2022
Via
Benzinga
Earnings Scheduled For November 2, 2022
November 02, 2022
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
May 06, 2022
Via
Benzinga
The Daily Biotech Pulse: AstraZeneca's 3 Product Updates, Jazz Pharma Licenses Sleeping Disorder Product, Argenx Aces Bleeding Disorder Study
May 05, 2022
Via
Benzinga
Earnings Scheduled For May 5, 2022
May 05, 2022
Via
Benzinga
Earnings Outlook For Vanda Pharmaceuticals
May 04, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 25, 2022
February 25, 2022
Via
Benzinga
10 Biggest Price Target Changes For Friday
February 25, 2022
Via
Benzinga
93 Biggest Movers From Friday
February 28, 2022
Via
Benzinga
The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company
February 24, 2022
Via
Benzinga
Vanda Pharmaceuticals: Q4 Earnings Insights
February 23, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
February 23, 2022
Via
Benzinga
Earnings Scheduled For February 23, 2022
February 23, 2022
Via
Benzinga
50 Biggest Movers From Friday
February 07, 2022
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
February 04, 2022
Via
Benzinga
Mid-Afternoon Market Update: Dow Turns Positive; Snap Shares Climb Following Upbeat Results
February 04, 2022
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
February 04, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.